MISCELLANEOUS LAWS
371
(c) “Practitioner,” for purposes of IC 16-42-21,
has the meaning set forth in IC 16-42-21-3.
(d) “Practitioner,” for purposes of IC 16-42-22,
and IC 16-42-25, has the meaning set forth in IC
16-42-22-4.5.
16-18-2-289. “Precursor” defined.
“Precursor,” for purposes of IC 16-42-19, has
the meaning set forth in IC 16-42-19-6.
16-18-2-292. “Prescription” defined.
“Prescription,” for purposes of IC 16-42-19,
has the meaning set forth in IC 16-42-19-7.
16-18-2-321. “Sale” defined.
(a) “Sale”, for purposes of IC 16-42-1 through
IC 16-42-4, includes the following:
(1) A sale.
(2) Manufacturing, processing, transport-
ing, handling, packing, canning, bottling,
or any other production, preparation, or
putting up.
(3) Exposure, offer, or any other proffer.
(4) Holding, storing, or any other posses-
sion.
(5) Dispensing, giving, delivering, serv-
ing, or any other supplying.
(6) Applying, administering, or any other
using.
(b) “Sale”, for purposes of IC 16-42-19, has
the meaning set forth in IC 16-42-19-8.
16-18-2-365. “Viability” defined.
“Viability” for purposes of IC 16-34, means the
ability of a fetus to live outside the mother’s
womb.
16-18-2-374. “Wholesaler” defined.
(a) “Wholesaler,” for purposes of IC 16-42-11,
has the meaning set forth in IC 16-42-11-1.1.
(b) “Wholesaler,” for purposes of IC 16-42-19
and IC 16-42-21, has the meaning set forth in IC
16-42-19-10.
(c) “Wholesaler,” for purposes of IC 16-41-32,
has the meaning set forth in IC 16-41-32-13.
TITLE 16
ARTICLE 42.
Chapter 19. Legend Drug Act.
16-42-19-1.
Act supplemental.
16-42-19-2.
“Drug” defined.
16-42-19-3.
“Drug order” defined.
16-42-19-4.
“Investigational or new drug” defined.
16-42-19-5.
“Practitioner” defined.
16-42-19-6.
“Precursor” defined.
16-42-19-7.
“Prescription” defined.
16-42-19-8.
“Sale” defined.
16-42-19-9.
“Warehouseman” defined.
16-42-19-10.
“Wholesaler” defined.
16-42-19-11.
Unlawful sale of legend drugs; excep-
tions.
16-42-19-12.
Refilling prescriptions.
16-42-19-13.
Possession or use of legend drug or pre-
cursor.
16-42-19-14.
Record-keeping requirements.
16-42-19-15.
Refusal of records inspection.
16-42-19-16.
Obtaining by fraud, deceit, etc.; forged
prescriptions.
16-42-19-17.
Possession of smoking instrument.
16-42-19-18.
Possession of syringe.
16-42-19-19.
Possession or use of anabolic steroids.
16-42-19-20.
Unlawful prescriptions.
16-42-19-21.
Exceptions.
16-42-19-22.
Manufacturers’and wholesalers’records.
16-42-19-23.
“Mechanical device” defined; offense.
16-42-19-24.
Nuisance.
16-42-19-25.
Anabolic steroids; offenses.
16-42-19-26.
Indictment and information; exceptions;
burden of proof.
16-42-19-27.
Penalties.
16-42-19-28.
Law enforcement officers exempted from
liability.
16-42-19-29.
Insulin sale by prescription only.
16-42-19-1. Act supplemental.
This chapter is intended to supplement IC 16-
42-1 through 16-42-4.
16-42-19-2. “Drug” defined.
As used in this chapter, "drug" means the fol-
lowing:
(1) Articles or substances recognized in
United States Pharmacopeial Convention,
Inc.; The United States Pharmacopeia,
Twenty-Second Edition (1990) or United
States Pharmacopeial Convention, Inc.;
The National Formulary, Seventeenth
Edition (1990) as revised by United States
Pharmacopeial
Convention,
Inc.;
Supplement 1 to The United States
Pharmacopeia, Twenty-Second Edition
